Pharmacolog AB and Codonics Inc. entered into a partnership agreement for sales and marketing of WasteLog for the North American market, which over time has been expanded to include sales of DrugLog and several regions, such as China, the Middle East region, the GCC countries and Jordan, Mexico and Canada. This agreement established minimum sales targets for the DrugLog and WasteLog products, which were not closely met for either product last year. As a result, Codonics was informed that the existing contract will be terminated in its entirety.

This means that Pharmacolog will in the future have the exclusive right to distribute the company's products in these regions. Furthermore, it is the board and management's assessment that this strengthens the conditions for successfully executing the company's strategy and divesting the remaining assets, which mainly consist of WasteLog and which has a larger installed base than DrugLog.